Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1 Gastrointestinal 1

Conditions

Motor Activity 1 Lymphoma, Non-Hodgkin 1 Hodgkin Disease 1

Interventions

Rituximab 702 Cyclophosphamide 643 Vincristine 352 Doxorubicin 307 Etoposide 303 Cytarabine 270 Filgrastim 250 Prednisone 248 Methotrexate 240 fludarabine phosphate 231 Dexamethasone 208 fludarabine 183 Peripheral Blood Stem Cell Transplantation 165 Radiotherapy 160 Granulocyte Colony-Stimulating Factor 145 Lenalidomide 144 Bendamustine Hydrochloride 142 Bortezomib 127 Melphalan 126 ibrutinib 111 Busulfan 110 Mycophenolic Acid 107 Whole-Body Irradiation 106 Tacrolimus 96 Cyclosporine 86 Gemcitabine 82 Ifosfamide 80 Alemtuzumab 80 Calcium Dobesilate 79 Leucovorin 77

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Accelerometry × Lymphoid × Clear all

NCT05188755 2022-12-23

CUPCAKE

University Hospital, Clermont-Ferrand

Phase NA Completed

Hodgkin Disease, Lymphoma, Non-Hodgkin, Motor Activity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡